The diverse and important contributions of the AHR to cancer and cancer immunity

Zhongyan Wang,Stefano Monti,David H. Sherr

DOI: https://doi.org/10.1016/j.cotox.2017.01.008

2017-02-01

Current Opinion in Toxicology

Abstract:With regard to its role in cancer, the AHR was originally described as a sensor of environmental carcinogens that, once activated, up-regulated monooxygenases responsible for the production of mutagenic metabolites. However, the AHR now appears to be play an ongoing role in cancer progression and tumor immunity. High AHR levels and constitutive activity in many types of cancers are consistent with the AHR's contribution to tumor progression. Here, we postulate that constitutive AHR activity is maintained, in part, through a positive amplification loop in which the AHR drives expression of tryptophan dioxygenases (IDO or TDO) which in turn contribute to the production of tryptophan-derived AHR ligands in malignant cells themselves and in non-malignant cells comprising the tumor microenvironment. The postulated consequences of this chronic AHR activity is increased malignant cell invasion, migration and metastasis, production of a subset of cells expressing cancer stem cell-like characteristics, and the creation of an immunosuppressive tumor environment. Therefore, drugs that inhibit or modulate AHR activity have the potential to both ameliorate tumor aggression directly and to act as immune checkpoint inhibitors.

English Else